Mir SA

ORCID: 0000-0002-3968-8434 · 2 papers in corpus

2022

Evaluation of the Safety and Efficacy of Ormeloxifene, a Selective Estrogen Receptor Modulator and Medroxyprogesterone Acetate in Women with Non-Structural Abnormal Uterine Bleeding: A Randomized Clinical Trial.

Medicina (Kaunas, Lithuania) ·doi:10.3390/medicina58111503

Background and objectives: Abnormal uterine bleeding is a significant clinical and gynaecological concern that necessitates its safe and effective treatment. The present study aims to compare the cost-effectiveness, safety, efficacy, and he…

review 2021

Endocrine disrupting chemical Bisphenol A and its potential effects on female health

Diabetes & metabolic syndrome ·doi:10.1016/j.dsx.2021.03.031

BACKGROUND AND AIM: A large number of chemical compounds with endocrine-disrupting activity have been documented. These chemicals are ubiquitous and widely used in many products of our daily lives. Bisphenol A (BPA) is among the most common…